[EN] NITROGEN-CONTAINING HETEROCYCLIC COMPOUND<br/>[FR] COMPOSÉ HÉTÉROCYCLIQUE CONTENANT DE L'AZOTE
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2013018929A1
公开(公告)日:2013-02-07
The present invention provides a novel compound having a superior activity as an ERR-α modulator and useful as an agent for the prophylaxis or treatment of ERR-α associated diseases. The present invention relates to a compound represented by the formula (1) wherein each symbol is as defined in the specification, or a salt thereof.
Provided is a compound having an agonist action on GPR52, which is useful as a prophylactic or therapeutic drug for mental diseases such as schizophrenia and the like, and the like.
A compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof.
bicyclic core structures with up to three stereocenters within a single step. Herein, this concept is combined with the chemistry of chiral Brønsted acid bound ortho-quinonemethideimines to generate a range of interesting fused tetrahydroquinolines in a diastereo- and enantioselective manner.
Four newsigmatropicsequences triggered by the regiocontrolled [2,3]-Wittig rearrangement of unsymmetrical bis-allylic ethers (1) to the l,5-dien-3-ols (2) arc described, which provide unique, regiocontrolled methods for the synthesis of a wide variety of unsaturatedcarbonylcompounds possessing interesting molecular frameworks. The newly developed sequences include the [2,3]-Wittig-Claisen, the
[EN] CARBON MONOXIDE-RELEASING MOLECULES TRIGGERED BY PHYSIOLOGICAL STIMULI<br/>[FR] MOLÉCULES À LIBÉRATION DE MONOXYDE DE CARBONE DÉCLENCHÉE PAR DES STIMULI PHYSIOLOGIQUES
申请人:UNIV GEORGIA STATE RES FOUND
公开号:WO2019032879A1
公开(公告)日:2019-02-14
The present invention generally relates to carbon monoxide releasing compounds and compositions, and their use as carbon monoxide prodrugs.